The National Cancer Institute (NCI) is offering this grant to continue support for the Cancer Immune Monitoring and Analysis Centers (CIMACs) and Cancer Immunologic Data Center (CIDC) Network. This grant is for establishing a network of laboratories (CIMACs) and a bioinformatics center (CIDC) dedicated to correlative studies using biospecimens from cancer immunotherapy clinical trials. The Network applies comprehensive immunoprofiling assays and bioinformatics pipelines, including genomics, transcriptomics, proteomics, and microbiome analyses of various biospecimen types. The ultimate goal is to identify biomarkers of response, resistance, and adverse events. This will optimize immunotherapy approaches for cancer patients by linking biomarker data from assays with clinical trial outcomes.
Opportunity ID: 342487
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-22-038 |
| Funding Opportunity Title: | Limited Competition: Cancer Immune Monitoring and Analysis Centers (CIMACs) and Cancer Immunologic Data Center (CIDC) (U24 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 15, 2022 |
| Last Updated Date: | Jul 15, 2022 |
| Original Closing Date for Applications: | Oct 24, 2022 |
| Current Closing Date for Applications: | Oct 24, 2022 |
| Archive Date: | Nov 29, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. see funding announcement for eligibility details |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Through this limited competition Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications to continue support for the Cancer Immune Monitoring and Analysis Centers Cancer Immunologic Data Center (CIMAC-CIDC) Network. The CIMAC-CIDC is a network of laboratories (CIMACs) and a bioinformatics center (CIDC) established to perform correlative studies using biospecimens from cancer immunotherapy clinical trials. Applying a comprehensive set of state-of-the-art immunoprofiling assays and bioinformatics pipelines, the CIMAC studies encompass genomics, transcriptomics, proteomics, microbiomes, and phenotyping analyses of tumor, tumor microenvironment, blood, stool, and other types of biospecimens. The ultimate goal of the CIMAC-CIDC Network is to identify biomarkers of response, resistance, and adverse events to optimize immunotherapy approaches for patients with cancer. CIMACs work with clinical trial teams and CIDC on correlative studies examining the association of biomarker data from the assays with clinical data from the trials. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-038.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00276016 | Sep 24, 2022 | Oct 24, 2022 | View |
Package 1
Mandatory forms
342487 RR_SF424_5_0-5.0.pdf
342487 PHS398_CoverPageSupplement_5_0-5.0.pdf
342487 RR_OtherProjectInfo_1_4-1.4.pdf
342487 PerformanceSite_4_0-4.0.pdf
342487 RR_KeyPersonExpanded_4_0-4.0.pdf
342487 RR_Budget_3_0-3.0.pdf
342487 PHS398_ResearchPlan_4_0-4.0.pdf
342487 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
342487 RR_SubawardBudget30_3_0-3.0.pdf
342487 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
